Organization
Monash University, CabriniHealth, Melbourne, Australia
1 abstract
Abstract
APREMILAST, AN ORAL PHOSPHODIESTERASE 4 INHIBITOR, IS ASSOCIATED WITH LONG-TERM (52-WEEK) IMPROVEMENTS IN BASDAI IN PATIENTS WITH PSORIATIC ARTHRITIS: POOLED RESULTS FROM 3 PHASE III, RANDOMIZED, CONTROLLED TRIALS Org: Swedish Medical Center and University of Washington School of Medicine, Seattle, United States, NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, United Kingdom, Clinical Research Centre Ltd, Tartu, Estonia, UZ Gent, Gent, Belgium, Schön Klinik Hamburg Eilbek, Hamburg, Germany,